Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
5.08
-0.41 (-7.47%)
At close: Apr 1, 2025, 4:00 PM
5.02
-0.06 (-1.18%)
After-hours: Apr 1, 2025, 7:57 PM EDT

Xeris Biopharma Holdings Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2016
Cash & Equivalents
71.6267.45121.9767.2737.6
Upgrade
Short-Term Investments
-5-35.1696.19
Upgrade
Cash & Short-Term Investments
71.6272.45121.97102.43133.79
Upgrade
Cash Growth
-1.15%-40.60%19.07%-23.44%77.09%
Upgrade
Accounts Receivable
40.4239.230.8317.466.88
Upgrade
Receivables
40.4239.230.8317.466.88
Upgrade
Inventory
48.1838.8424.7418.128.35
Upgrade
Prepaid Expenses
7.455.789.294.593.2
Upgrade
Total Current Assets
167.66156.26186.82142.6152.21
Upgrade
Property, Plant & Equipment
28.2129.189.516.636.71
Upgrade
Goodwill
22.8622.8622.8622.86-
Upgrade
Other Intangible Assets
98.92109.76120.61131.45-
Upgrade
Other Long-Term Assets
5.414.544.730.830.23
Upgrade
Total Assets
323.06322.6344.52304.36159.15
Upgrade
Accounts Payable
2.2911.574.618.923.12
Upgrade
Accrued Expenses
56.845.6644.0951.1721.07
Upgrade
Current Portion of Long-Term Debt
15.1----
Upgrade
Current Portion of Leases
6.083.51.58--
Upgrade
Other Current Liabilities
20.1734.4723.3518.954.02
Upgrade
Total Current Liabilities
100.4495.1973.6279.0428.21
Upgrade
Long-Term Debt
217.01190.93187.0888.0787.02
Upgrade
Long-Term Leases
33.2634.769.4--
Upgrade
Long-Term Deferred Tax Liabilities
-2.273.524.94-
Upgrade
Other Long-Term Liabilities
1.976.2325.7237.0810.16
Upgrade
Total Liabilities
352.68329.38299.34209.13125.39
Upgrade
Common Stock
0.020.010.010.010.01
Upgrade
Additional Paid-In Capital
642.26610.25599.97555.36371.13
Upgrade
Retained Earnings
-671.86-617.03-554.77-460.11-337.39
Upgrade
Comprehensive Income & Other
-0.03-0.03-0.02-0.030.01
Upgrade
Total Common Equity
-29.62-6.7845.1995.2333.76
Upgrade
Shareholders' Equity
-29.62-6.7845.1995.2333.76
Upgrade
Total Liabilities & Equity
323.06322.6344.52304.36159.15
Upgrade
Total Debt
271.45229.19198.0688.0787.02
Upgrade
Net Cash (Debt)
-199.83-156.74-76.0914.3746.77
Upgrade
Net Cash Growth
----69.28%171.21%
Upgrade
Net Cash Per Share
-1.36-1.14-0.560.181.10
Upgrade
Filing Date Shares Outstanding
153.94140.45137.29135.5259.76
Upgrade
Total Common Shares Outstanding
149.43138.13136.27124.8759.61
Upgrade
Working Capital
67.2261.07113.263.56124.01
Upgrade
Book Value Per Share
-0.20-0.050.330.760.57
Upgrade
Tangible Book Value
-151.4-139.41-98.28-59.0833.76
Upgrade
Tangible Book Value Per Share
-1.01-1.01-0.72-0.470.57
Upgrade
Machinery
6.265.655.685.434.32
Upgrade
Leasehold Improvements
6.065.985.075.034.63
Upgrade
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q